BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 20532456)

  • 1. Reconciling Q waves and late gadolinium enhancement with no angiographic evidence of coronary disease: cardiac sarcoidosis presenting as decompensated heart failure.
    Morrissey RP; Philip KJ; Schwarz ER
    Cardiovasc J Afr; 2010; 21(3):158-63. PubMed ID: 20532456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fragmented QRS complexes on 12-lead ECG: a marker of cardiac sarcoidosis as detected by gadolinium cardiac magnetic resonance imaging.
    Homsi M; Alsayed L; Safadi B; Mahenthiran J; Das MK
    Ann Noninvasive Electrocardiol; 2009 Oct; 14(4):319-26. PubMed ID: 19804507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac Sarcoidosis.
    Kouranos V; Tzelepis GE; Rapti A; Mavrogeni S; Aggeli K; Douskou M; Prasad S; Koulouris N; Sfikakis P; Wells A; Gialafos E
    JACC Cardiovasc Imaging; 2017 Dec; 10(12):1437-1447. PubMed ID: 28330653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart block in a 60-year-old man with undiagnosed cardiac sarcoidosis.
    Pirzada A; Moeller AD
    CMAJ; 2022 Feb; 194(8):E306-E309. PubMed ID: 35228322
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiac sarcoidosis detected by late gadolinium enhancement and prevalence of atrial arrhythmias.
    Cain MA; Metzl MD; Patel AR; Addetia K; Spencer KT; Sweiss NJ; Beshai JF
    Am J Cardiol; 2014 May; 113(9):1556-60. PubMed ID: 24731652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcoid Heart Disease: Review of Current Knowledge.
    Jin C; Gandrabur L; Kim WY; Pan S; Ash JY
    Cardiol Rev; 2023 Jan-Feb 01; 31(1):28-35. PubMed ID: 34132655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of cardiac MRI and 18F-FDG positron emission tomography manifestations and regional response to corticosteroid therapy in newly diagnosed cardiac sarcoidosis with complet heart block.
    Orii M; Hirata K; Tanimoto T; Ota S; Shiono Y; Yamano T; Matsuo Y; Ino Y; Yamaguchi T; Kubo T; Tanaka A; Akasaka T
    Heart Rhythm; 2015 Dec; 12(12):2477-85. PubMed ID: 26111805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Usefulness of late gadolinium enhancement combined with MRI and 67-Ga scintigraphy in the diagnosis of cardiac sarcoidosis and disease activity evaluation.
    Kiuchi S; Teraoka K; Koizumi K; Takazawa K; Yamashina A
    Int J Cardiovasc Imaging; 2007 Apr; 23(2):237-41. PubMed ID: 16868855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A heart insufficiency treated by glucocorticoids].
    Froidevaux L; Levotanec I; Waeber G
    Praxis (Bern 1994); 2007 Oct; 96(42):1643-7. PubMed ID: 17974124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What type of different clinical manifestations can cardiac sarcoidosis present?
    Şentürk A; Maraş Y; Argüder E; Karalezli A; Hasanoğlu HC; Öğüt T; Baştuğ S; Karabekir E
    Rheumatol Int; 2015 Jun; 35(6):1103-6. PubMed ID: 25429793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of late gadolinium enhancement in predicting arrhythmic events in cardiac sarcoidosis patients - a mini-review.
    Bazoukis G; Liatakis I; Vassiliou VS; Tse G; Gounopoulos P; Saplaouras A; Letsas KP; Vlachos K; Papadatos SS; Konstantinidou E; Lakoumentas I; Sideris A; Efremidis M
    Acta Cardiol; 2022 Nov; 77(9):768-773. PubMed ID: 35086421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adalimumab for the treatment of cardiac sarcoidosis with multiple arrhythmias.
    Li S; Wang H; Liu T; Li Q; Yang X; Xiong R; Lv Q; Du X; Dong J; Ma C
    ESC Heart Fail; 2022 Dec; 9(6):4325-4329. PubMed ID: 36043423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of cardiovascular magnetic resonance in patients with biopsy-proven systemic sarcoidosis.
    Flamée L; Symons R; Degtiarova G; Dresselaers T; Gheysens O; Wuyts W; Van Cleemput J; Bogaert J
    Eur Radiol; 2020 Jul; 30(7):3702-3710. PubMed ID: 32166494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac manifestations of sarcoidosis: diagnosis and management.
    Birnie DH; Kandolin R; Nery PB; Kupari M
    Eur Heart J; 2017 Sep; 38(35):2663-2670. PubMed ID: 27469375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early diagnosis of cardiac sarcoidosis using magnetic resonance imaging.
    Osman F; Foundon A; Leyva P; Pitt M; Murray RG
    Int J Cardiol; 2008 Mar; 125(1):e4-5. PubMed ID: 17337076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cardiac sarcoidosis: diagnostics, treatment and follow-up].
    Dudziak M; Jankowska H; Dorniak K
    Pol Merkur Lekarski; 2018 Mar; 44(261):124-129. PubMed ID: 29601561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete heart block in cardiac sarcoidosis reversed by corticosteroid therapy: time course of resolution.
    Tomdio A; Syed H; Ellenbogen K; Kron J
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33687942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular asynchrony in early isolated cardiac sarcoidosis.
    Nagai T; Arakawa J; Fujikawa A; Kastushika S
    Eur Heart J Cardiovasc Imaging; 2016 Jan; 17(1):40. PubMed ID: 26578651
    [No Abstract]   [Full Text] [Related]  

  • 19. Late gadolinium enhanced high resolution magnetic resonance imaging reveals pathophysiological condition of cardiac sarcoidosis.
    Niida T; Isoda K; Sasaki M; Horikawa M; Hayashi K; Ohsuzu F
    Int Heart J; 2009 Mar; 50(2):263-6. PubMed ID: 19367036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and prognostic significance of myocardial late gadolinium enhancement in patients with sarcoidosis without cardiac manifestation.
    Nagai T; Kohsaka S; Okuda S; Anzai T; Asano K; Fukuda K
    Chest; 2014 Oct; 146(4):1064-1072. PubMed ID: 24853830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.